159 related articles for article (PubMed ID: 26920997)
41. Among human macrophages polarised to different phenotypes, the M-CSF-oriented cells present the highest pro-inflammatory response to the rheumatoid arthritis-specific immune complexes containing ACPA.
Clavel C; Ceccato L; Anquetil F; Serre G; Sebbag M
Ann Rheum Dis; 2016 Dec; 75(12):2184-2191. PubMed ID: 27009917
[TBL] [Abstract][Full Text] [Related]
42. Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate.
Parker A; Izmailova ES; Narang J; Badola S; Le T; Roubenoff R; Ginsburg GS; Maier A; Coblyn JS; Shadick NA; Weinblatt ME
J Rheumatol; 2007 Sep; 34(9):1817-22. PubMed ID: 17696278
[TBL] [Abstract][Full Text] [Related]
43. Methotrexate and cyclooxygenase metabolism in cultured human rheumatoid synoviocytes.
Vergne P; Liagre B; Bertin P; Cook-Moreau J; Treves R; Beneytout JL; Rigaud M
J Rheumatol; 1998 Mar; 25(3):433-40. PubMed ID: 9517759
[TBL] [Abstract][Full Text] [Related]
44. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
Kapetanovic MC; Roseman C; Jönsson G; Truedsson L; Saxne T; Geborek P
Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061
[TBL] [Abstract][Full Text] [Related]
45. Semaphorin 3G exacerbates joint inflammation through the accumulation and proliferation of macrophages in the synovium.
Shoda J; Tanaka S; Etori K; Hattori K; Kasuya T; Ikeda K; Maezawa Y; Suto A; Suzuki K; Nakamura J; Maezawa Y; Takemoto M; Betsholtz C; Yokote K; Ohtori S; Nakajima H
Arthritis Res Ther; 2022 Jun; 24(1):134. PubMed ID: 35659346
[TBL] [Abstract][Full Text] [Related]
46. Methotrexate increases expression of cell cycle checkpoint genes via JNK activation.
Spurlock CF; Tossberg JT; Fuchs HA; Olsen NJ; Aune TM
Arthritis Rheum; 2012 Jun; 64(6):1780-9. PubMed ID: 22183962
[TBL] [Abstract][Full Text] [Related]
47. Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive Macrophages and a Novel Target to Treat Diseases With Macrophage Imbalances.
Ohradanova-Repic A; Machacek C; Charvet C; Lager F; Le Roux D; Platzer R; Leksa V; Mitulovic G; Burkard TR; Zlabinger GJ; Fischer MB; Feuillet V; Renault G; Blüml S; Benko M; Suchanek M; Huppa JB; Matsuyama T; Cavaco-Paulo A; Bismuth G; Stockinger H
Front Immunol; 2018; 9():852. PubMed ID: 29780382
[TBL] [Abstract][Full Text] [Related]
48. The advances of methotrexate resistance in rheumatoid arthritis.
Yu J; Zhou P
Inflammopharmacology; 2020 Oct; 28(5):1183-1193. PubMed ID: 32757110
[TBL] [Abstract][Full Text] [Related]
49. [Weekly low-dose methotrexate in rheumatoid arthritis. Review of the literature].
Manganelli P; Troise Rioda W
Minerva Med; 1993 Oct; 84(10):541-52. PubMed ID: 8247309
[TBL] [Abstract][Full Text] [Related]
50. [Pharmacogenomics of methrotexate: a strategy for a customized therapeutic scheme for patients with rheumatoid arthritis].
Mena-Ramírez JP; Salazar-Páramo M; Dávalos-Rodríguez IP
Gac Med Mex; 2008; 144(5):449-51. PubMed ID: 19043967
[TBL] [Abstract][Full Text] [Related]
51. Methotrexate transport mechanisms: the basis for targeted drug delivery and ß-folate-receptor-specific treatment.
Fiehn C
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S40-5. PubMed ID: 21044432
[TBL] [Abstract][Full Text] [Related]
52. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ
Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
[TBL] [Abstract][Full Text] [Related]
53. The suppression of rat collagen-induced arthritis and inhibition of macrophage derived mediator release by liposomal methotrexate formulations.
Williams A; Goodfellow R; Topley N; Amos N; Williams B
Inflamm Res; 2000 Apr; 49(4):155-61. PubMed ID: 10858015
[TBL] [Abstract][Full Text] [Related]
54. Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritis.
Furst DE
Br J Rheumatol; 1995 Nov; 34 Suppl 2():20-5. PubMed ID: 8535644
[TBL] [Abstract][Full Text] [Related]
55. Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis.
Nakashima-Matsushita N; Homma T; Yu S; Matsuda T; Sunahara N; Nakamura T; Tsukano M; Ratnam M; Matsuyama T
Arthritis Rheum; 1999 Aug; 42(8):1609-16. PubMed ID: 10446858
[TBL] [Abstract][Full Text] [Related]
56. Effects and interaction of 7-hydroxy methotrexate and methotrexate in leukaemic cells ex vivo measured by the thymidylate synthase inhibition assay.
Lingg RM; Hempel G; Rots MG; Van Zantwijk CH; Boos J; Kaspers GJ
Cancer Chemother Pharmacol; 2005 Sep; 56(3):322-7. PubMed ID: 15868145
[TBL] [Abstract][Full Text] [Related]
57. Lack of evidence for inhibition of angiogenesis as a central mechanism of the antiarthritic effect of methotrexate.
Fiehn C; Wunder A; Krienke S; Max R; Ho AD; Moehler T
Rheumatol Int; 2005 Mar; 25(2):108-13. PubMed ID: 14618373
[TBL] [Abstract][Full Text] [Related]
58. Genome-wide analysis of methotrexate pharmacogenomics in rheumatoid arthritis shows multiple novel risk variants and leads for TYMS regulation.
Senapati S; Singh S; Das M; Kumar A; Gupta R; Kumar U; Jain S; Juyal RC; Thelma BK
Pharmacogenet Genomics; 2014 Apr; 24(4):211-9. PubMed ID: 24583629
[TBL] [Abstract][Full Text] [Related]
59. In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4(+) T lymphocytes.
Ellingsen T; Hornung N; Møller BK; Hjelm-Poulsen J; Stengaard-Pedersen K
Scand J Immunol; 2007 Oct; 66(4):451-7. PubMed ID: 17850590
[TBL] [Abstract][Full Text] [Related]
60. Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update.
Zhu H; Deng FY; Mo XB; Qiu YH; Lei SF
Pharmacogenomics; 2014 Mar; 15(4):551-66. PubMed ID: 24624921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
